US Stock MarketDetailed Quotes

GLUE Monte Rosa Therapeutics

Watchlist

5.800
-1.260-17.85%

Close Mar 21 16:00 ET

5.898
+0.098+1.69%

Post 20:01 ET

356.76MMarket Cap-5.92P/E (TTM)

Monte Rosa Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Monte Rosa Therapeutics Q4 2024 Earnings Date

Currency：USDMar 20, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	51.19M	60.65M	+9.46M
Beat Est.	--	--	+18.47%
EPS	0.01	0.22	+0.20
Beat Est.	+102.53%	+137.67%	+1386.39%

Analyst Rating

Strong Buy

Mar 21, 2025

Monte Rosa Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 13.567M	--
--	2025/Q1	-- / 13.567M	--
Mar 20, 2025	2024/Q4	60.647M / 51.192M	--
--	2024/Q3	9.216M / 3.249M	--
--	2024/Q2	4.695M / 1.349M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 13.567M--

--2025/Q1-- / 13.567M--

Mar 20, 20252024/Q460.647M / 51.192M--

--2024/Q39.216M / 3.249M--

--2024/Q24.695M / 1.349M--

Unlock Free Earnings Estimates

Open Account

Monte Rosa Therapeutics Earnings Reports

Monte Rosa Therapeutics | 10-K: FY2024 Annual Report

Mar 20 09:05 ET

Monte Rosa Therapeutics | 8-K: Monte Rosa Therapeutics Announces Fourth Quarter 2024 Financial Results and Provides Corporate Update Including New Clinical Results from MRT-6160 and MRT-2359 Programs

Mar 20 07:04 ET

Monte Rosa Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 7, 2024 07:13 ET

Monte Rosa Therapeutics | 8-K: Monte Rosa Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 7, 2024 07:08 ET